330 MEDx HRDetectCDx predicts the response of newly diagnosed advanced ovarian cancer patients in china to first-line maintenance treatment with niraparibJing Zuo,Ke Wang, Zhumei Cui, Hui Zhang,Qingshui Li, Shuhe Wang,Lixin Sun, Jun Zhang,Min Zheng,Hongqin Zhao,Xiaoxiang Chen,Xiaodong Cheng, Li Hong,Yang Gao, Wenhui Song,Yu Wang, Jiaxing Zhao, Zeyu Jiang, Yafei Zhang,Lingying WuPoster and E-Posters（2024）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
